{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-001941","form_type":"8-K/A","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2023-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.330386+00:00","generated_at":"2026-06-20T13:06:25.666923+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetVivo raises $1.42M gross via registered direct offering of 610,011 shares at $2.32/share","bullets":["610,011 shares sold at $2.32/share; gross proceeds $1,415,225.52.","Net proceeds ~$1.39M after $25k expenses; closings on Jan 9 and Jan 13, 2023.","Proceeds for commercialization of Spryng™ with OsteoCushion™ Tech, clinical trials, working capital.","Offering directly to accredited investors; no placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-001941","json":"https://secwatch.observer/filing/0001493152-23-001941.json","markdown":"https://secwatch.observer/filing/0001493152-23-001941.md","text":"https://secwatch.observer/filing/0001493152-23-001941.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/0001493152-23-001941-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T13:06:25.666923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2895b022b99c76a2bab40d0248a8a059c266e2b3","claim":"PetVivo Holdings, Inc. amended Amended Purchase Agreement with certain accredited investors valued at $1,415,225.52 (effective 2023-01-05).","evidence_excerpt":"On January 5, 2023, PetVivo Holdings, Inc. (the “Company”) entered into an amended and restated securities purchase agreement with certain accredited investors (the “Amended Purchase Agreement”), pursuant to which the Company agreed to issue and sell an aggregate of 610,011 Registered Shares in the Registered Offering at a purchase price of $2.32 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223001941/0001493152-23-001941-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$1,415,225.52"},{"label":"Effective","value":"2023-01-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}